Spyre Therapeutics Inc (SYRE)

01:46 AM

What does recent volatility data suggest for Spyre Therapeutics Inc.Market Movement Recap & AI Enhanced Trading Signals - newser.com

01:46 AM

01:08 AM

Published on: 2025-09-16 12:08:18 - newser.com

01:08 AM

12:48 PM

US Market Recap: Is Spyre Therapeutics Inc stock good for income investors2025 AllTime Highs & Weekly High Return Stock Opportunities - خودرو بانک

12:48 PM

07:34 AM

Spyre Therapeutics (SYRE): Analyst Reiterates Buy Rating | SYRE Stock News - GuruFocus

07:34 AM

06:50 AM

Can you recover from losses in Spyre Therapeutics Inc.Quarterly Profit Review & Capital Efficiency Focused Strategies - newser.com

06:50 AM

04:31 AM

Spyre Therapeutics, Inc. $SYRE Shares Bought by Woodline Partners LP - MarketBeat

04:31 AM

03:56 AM

Support Test: Is Spyre Therapeutics Inc benefiting from interest rate changesQuarterly Portfolio Report & Fast Moving Stock Trade Plans - خودرو بانک

03:56 AM

03:20 AM

Tools to monitor Spyre Therapeutics Inc. recovery probabilityEarnings Recap Report & Entry Point Confirmation Alerts - newser.com

03:20 AM

12:21 PM

Growth Recap: Is Spyre Therapeutics Inc stock good for income investorsJuly 2025 Selloffs & Free Weekly Chart Analysis and Trade Guides - خودرو بانک

12:21 PM

12:03 PM

Value Recap: Is Spyre Therapeutics Inc a top pick in the sectorJuly 2025 Trends & Weekly Consistent Profit Watchlists - خودرو بانک

12:03 PM

Sep 15, 2025

Is Spyre Therapeutics Inc. stock bottoming out2025 Bull vs Bear & Smart Money Movement Tracker - newser.com

Sep 15, 2025

Sep 15, 2025

History Review: What are Spyre Therapeutics Inc.’s growth leversJuly 2025 Movers & AI Enhanced Execution Alerts - خودرو بانک

Sep 15, 2025

Sep 15, 2025

What Fibonacci levels say about Spyre Therapeutics Inc. reboundBull Run & Fast Exit/Entry Strategy Plans - newser.com

Sep 15, 2025

Sep 15, 2025

Spyre Therapeutics (SYRE) Doses First Patient In Promising SPY072 Phase 2 Trial - Yahoo Finance

Sep 15, 2025

Sep 15, 2025

Spyre Therapeutics doses first patient in phase 2 rheumatic disease trial - Investing.com

Sep 15, 2025

Sep 15, 2025

Spyre Flat on Test Result - Baystreet.ca

Sep 15, 2025

Sep 15, 2025

Spyre Therapeutics doses first patient in phase 2 rheumatic disease trial By Investing.com - Investing.com South Africa

Sep 15, 2025

Sep 15, 2025

Spyre doses first patient in phase 2 SKYWAY trial of SPY072, first anti-TL1A antibody for rheumatic diseases - MarketScreener

Sep 15, 2025

Sep 15, 2025

First-Ever Anti-TL1A Drug for 3M+ Rheumatic Patients: Spyre's SPY072 Enters Phase 2 Trial - Stock Titan

Sep 15, 2025

Sep 15, 2025

Detecting support and resistance levels for Spyre Therapeutics Inc.July 2025 Gainers & Technical Pattern Based Buy Signals - newser.com

Sep 15, 2025

Sep 15, 2025

Chart overlay techniques for tracking Spyre Therapeutics Inc.Entry Point & High Conviction Buy Zone Picks - newser.com

Sep 15, 2025

Sep 15, 2025

Automated trading signals detected on Spyre Therapeutics Inc.2025 Institutional Moves & Weekly Chart Analysis and Guides - newser.com

Sep 15, 2025

Sep 14, 2025

Does Spyre Therapeutics Inc. qualify in momentum factor screeningGold Moves & Risk Controlled Stock Alerts - newser.com

Sep 14, 2025

Sep 14, 2025

How to use a screener to detect Spyre Therapeutics Inc. breakoutsJuly 2025 Drop Watch & AI Powered Market Entry Strategies - newser.com

Sep 14, 2025

Sep 13, 2025

We're Hopeful That Spyre Therapeutics (NASDAQ:SYRE) Will Use Its Cash Wisely - 富途牛牛

Sep 13, 2025

Sep 12, 2025

Order flow analysis tools used on Spyre Therapeutics Inc.2025 AllTime Highs & Daily Volume Surge Trade Alerts - Newser

Sep 12, 2025

Sep 12, 2025

What’s next for Spyre Therapeutics Inc. stock price2025 Technical Overview & Safe Entry Trade Signal Reports - Newser

Sep 12, 2025

Sep 12, 2025

Does Spyre Therapeutics Inc. fit your quant trading model2025 Market Outlook & Momentum Based Trading Signals - Newser

Sep 12, 2025

Sep 12, 2025

Smart tools for monitoring Spyre Therapeutics Inc.’s price action2025 Trade Ideas & Consistent Growth Equity Picks - Newser

Sep 12, 2025

Sep 12, 2025

Combining price and volume data for Spyre Therapeutics Inc.Market Performance Recap & AI Driven Stock Price Forecasts - Newser

Sep 12, 2025

Sep 12, 2025

Wall Street Zen Upgrades Spyre Therapeutics (NASDAQ:SYRE) to "Hold" - MarketBeat

Sep 12, 2025

Sep 12, 2025

Exit strategy if you’re trapped in Spyre Therapeutics Inc.Dollar Strength & Consistent Return Investment Signals - Newser

Sep 12, 2025

Sep 12, 2025

Has Spyre Therapeutics Inc. formed a bullish divergenceWeekly Earnings Recap & Low Volatility Stock Suggestions - Newser

Sep 12, 2025

Sep 12, 2025

Technical signs of recovery in Spyre Therapeutics Inc.July 2025 Decliners & Weekly Market Pulse Updates - Newser

Sep 12, 2025

Sep 12, 2025

Spyre Therapeutics Inc. stock momentum explained2025 Historical Comparison & Growth Focused Investment Plans - Newser

Sep 12, 2025

Sep 12, 2025

Can swing trading help recover from Spyre Therapeutics Inc. losses2025 Analyst Calls & Consistent Profit Trade Alerts - Newser

Sep 12, 2025

Sep 12, 2025

Real time pattern detection on Spyre Therapeutics Inc. stockQuarterly Trade Review & Daily Risk Controlled Trade Plans - Newser

Sep 12, 2025

Sep 11, 2025

What high frequency data says about Spyre Therapeutics Inc.Market Trend Review & Risk Managed Investment Strategies - Newser

Sep 11, 2025

Sep 11, 2025

Should you hold or exit Spyre Therapeutics Inc. now2025 Market Overview & Safe Entry Point Identification - Newser

Sep 11, 2025

Sep 11, 2025

Is Spyre Therapeutics Inc. forming a bottoming basePortfolio Return Report & Free Expert Approved Momentum Trade Ideas - Newser

Sep 11, 2025